EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Progress in Orthotopic Pig Heart Transplantation in Nonhuman Primates

Matthias Längin, Martin Bender, Michael Schmoeckel, Bruno Reichart

Transplant International · 2024

DOI: 10.3389/ti.2024.13607 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Transplant International, 2024. Verfasst von Matthias Längin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, LMU University Hospital, LMU Munich, Munich, Germany. Hauptthemen laut MEDLINE: Heart Transplantation, Transplantation, Heterologous, Graft Rejection, Primates. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Xenotransplantation of porcine hearts has become a promising alternative to human allotransplantation, where organ demand still greatly surpasses organ availability. Before entering the clinic, however, feasibility of cardiac xenotransplantation needs to be proven, ideally in the life supporting orthotopic pig-to-nonhuman primate xenotransplantation model. In this review, we shortly outline the last three decades of research and then discuss in detail its most recent advances. These include the genetic modifications of donor pigs to overcome hyperacute rejection and coagulation dysregulation, new organ preservation methods to prevent perioperative xenograft dysfunction, experimental immunosuppressive and immunomodulatory therapies to inhibit the adaptive immune system and systemic inflammation in the recipient, growth control concepts to avoid detrimental overgrowth of the porcine hearts in nonhuman primates, and lastly, the avoidance of porcine cytomegalovirus infections in donor pigs. With these strategies, consistent survival of 6–9 months was achieved in the orthotopic xenotransplantation model, thereby fulfilling the prerequisites for the initiation of a clinical trial.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart TransplantationTransplantation, HeterologousGraft RejectionPrimatesAnimalsSwineHumansGraft SurvivalOrgan PreservationImmunosuppressive AgentsHeterografts

Stichwörter der Autor:innen

costimulation blockadegenetically-modified pigorgan perfusionorthotopic heart transplantationxenotransplantation

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Department of Anesthesiology, LMU University Hospital, LMU Munich, Munich, Germany.
  • Department of Cardiac Surgery, LMU University Hospital, LMU Munich, Munich, Germany.
  • Transregional Collaborative Research Center 127, Walter Brendel Centre of Experimental Medicine, LMU Munich, Munich, Germany.

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Längin, M., Bender, M., Schmoeckel, M., & Reichart, B. (2024). Progress in Orthotopic Pig Heart Transplantation in Nonhuman Primates. Transplant International. https://doi.org/10.3389/ti.2024.13607

Vancouver

Längin M, Bender M, Schmoeckel M, Reichart B. Progress in Orthotopic Pig Heart Transplantation in Nonhuman Primates. Transplant International. 2024. doi:10.3389/ti.2024.13607

BibTeX
@article{Lngin2024,
  author = {Längin, Matthias and Bender, Martin and Schmoeckel, Michael and Reichart, Bruno},
  title = {Progress in Orthotopic Pig Heart Transplantation in Nonhuman Primates},
  journal = {Transplant International},
  year = {2024},
  doi = {10.3389/ti.2024.13607}
}
Kostenlos starten →